BIDU-SW
09888
BOSS ZHIPIN-W
02076
NTES-S
09999
4
BABA-W
09988
5
TENCENT
00700
(FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -30.92%61.83M | -32.12%31.46M | -7.27%89.51M | 3.68%46.35M | 8.24%96.53M | -6.98%44.7M | -21.97%89.18M | -16.65%48.05M | -0.89%114.28M | 4.40%57.65M |
Operating income | -30.92%61.83M | -32.12%31.46M | -7.27%89.51M | 3.68%46.35M | 8.24%96.53M | -6.98%44.7M | -21.97%89.18M | -16.65%48.05M | -0.89%114.28M | 4.40%57.65M |
Cost of sales | 30.66%-42.92M | 33.57%-22.28M | 8.52%-61.9M | -6.47%-33.54M | -8.94%-67.66M | 7.69%-31.5M | 24.03%-62.11M | 18.93%-34.12M | -2.04%-81.75M | -10.92%-42.09M |
Operating expenses | 30.66%-42.92M | 33.57%-22.28M | 8.52%-61.9M | -6.47%-33.54M | -8.94%-67.66M | 7.69%-31.5M | 24.03%-62.11M | 18.93%-34.12M | -2.04%-81.75M | -10.92%-42.09M |
Gross profit | -31.49%18.92M | -28.33%9.18M | -4.34%27.61M | -2.96%12.81M | 6.62%28.86M | -5.23%13.2M | -16.79%27.07M | -10.48%13.93M | -7.54%32.54M | -9.93%15.56M |
Selling expenses | 16.59%-11.51M | 18.16%-5.92M | -10.30%-13.8M | -24.58%-7.23M | -11.76%-12.51M | -1.50%-5.81M | 9.66%-11.19M | 12.78%-5.72M | 16.26%-12.39M | 4.03%-6.56M |
Administrative expenses | 26.99%-6.95M | 24.32%-3.43M | 0.72%-9.51M | 3.78%-4.53M | 2.28%-9.58M | 1.30%-4.71M | 11.82%-9.81M | 7.36%-4.77M | 5.69%-11.12M | 21.32%-5.15M |
Special items of operating profit | 46.22%1.68M | 128.50%930K | 85.05%1.15M | 43.31%407K | -70.15%622K | -81.02%284K | -12.51%2.08M | 34.65%1.5M | 158.63%2.38M | 181.98%1.11M |
Operating profit | -60.64%2.15M | -47.53%764K | -26.27%5.45M | -51.03%1.46M | -9.35%7.4M | -39.78%2.97M | -28.48%8.16M | -0.58%4.94M | 19.80%11.41M | 15.65%4.97M |
Financing cost | 5.95%-711K | 3.80%-380K | 13.10%-756K | 7.71%-395K | -5.97%-870K | -8.35%-428K | -11.25%-821K | -10.03%-395K | -225.11%-738K | -174.05%-359K |
Earning before tax | -69.44%1.44M | -63.81%384K | -28.03%4.7M | -58.31%1.06M | -11.07%6.53M | -43.97%2.55M | -31.22%7.34M | -1.41%4.54M | 14.78%10.67M | 10.67%4.61M |
Tax | 20.64%-646K | 55.79%-145K | 40.32%-814K | 51.19%-328K | 3.74%-1.36M | 36.18%-672K | 23.94%-1.42M | -7.12%-1.05M | -49.04%-1.86M | -24.59%-983K |
After-tax profit from continuing operations | -79.68%789K | -67.39%239K | -24.78%3.88M | -60.86%733K | -12.82%5.16M | -46.32%1.87M | -32.77%5.92M | -3.73%3.49M | 9.46%8.81M | 7.41%3.62M |
Earning after tax | -79.68%789K | -67.39%239K | -24.78%3.88M | -60.86%733K | -12.82%5.16M | -46.32%1.87M | -32.77%5.92M | -3.73%3.49M | 9.46%8.81M | 7.41%3.62M |
Minority profit | -52.73%468K | -118.18%-14K | 60.19%990K | -68.95%77K | -44.62%618K | -51.75%248K | -19.77%1.12M | 41.60%514K | -29.28%1.39M | -54.05%363K |
Profit attributable to shareholders | -88.90%321K | -61.43%253K | -36.34%2.89M | -59.63%656K | -5.43%4.54M | -45.38%1.63M | -35.20%4.8M | -8.77%2.98M | 22.00%7.41M | 26.20%3.26M |
Basic earnings per share | -85.71%0.0002 | -66.67%0.0001 | -39.13%0.0014 | -62.50%0.0003 | -4.17%0.0023 | -46.67%0.0008 | -35.14%0.0024 | -6.25%0.0015 | 12.12%0.0037 | 6.67%0.0016 |
Diluted earnings per share | -85.71%0.0002 | -66.67%0.0001 | -39.13%0.0014 | -62.50%0.0003 | -4.17%0.0023 | -46.67%0.0008 | -35.14%0.0024 | -6.25%0.0015 | 12.12%0.0037 | 6.67%0.0016 |
Currency Unit | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | -- | -- | Ernst & Young LLP | -- | Ernst & Young LLP | -- | Ernst & Young LLP | -- | Ernst & Young LLP | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.